Catalyst Pharmaceutical Partners News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.09.24	Catalyst Pharma's Sub-licensee, DyDo, Secures Regulatory Approval For FIRDAPSE In Japan (RTTNews)
21.09.24	FDA Approval Propels ZVRA To 52-week High, ADMA, CPRX, TVTX Also Reach New Peaks (RTTNews)
20.09.24	EWTX Yields Over 300% Returns, ADMA Records 200% Gains - Did You Strike While The Iron Is Hot? (RTTNews)
30.05.24	Biotech Stocks Facing FDA Decision In June 2024 (RTTNews)
13.03.24	Catalyst Pharmaceutical Gains Following US Commercial Launch Of Agamree (RTTNews)
05.01.24	Catalyst Pharma Prices 10 Mln Share Offering At $15/shr; Shares Tank In Pre-market (RTTNews)
18.12.23	Catalyst Pharma Says FIRDAPSE NDA Submitted In Japan By Partner DyDo Pharma (RTTNews)
04.12.23	Catalyst Pharma Names Michael Kalb CFO Effective Jan. 1, Succeeding Alicia Grande (RTTNews)
19.10.23	Catalyst Pharma Appoints Richard Daly To Succeed Patrick McEnany As CEO (RTTNews)
13.10.23	Catalyst Pharma Reports FDA Acceptance Of SNDA For FIRDAPSE (RTTNews)
19.07.23	Catalyst Pharma Concludes Purchase Of North American Rights For Vamorolone From Santhera Pharma (RTTNews)
20.06.23	Santhera Grants North America License For Vamorolone To Catalyst Pharma (RTTNews)
13.09.22	Catalyst Pharmaceuticals Set to Join S&P SmallCap 600 (PR Newswire)
12.07.22	Catalyst Pharma Acquires U.S. And Mexico Rights To Ruzurgi (RTTNews)
17.03.22	AKU's Q4 Revenue Up 168%, CPRX Expects 2022 Revenue To Grow 38%-45%, VIRX Awaits NAVAL-1 Trial Data (RTTNews)
11.08.20	CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs (RTTNews)
13.09.19	5 Top Losers In Healthcare Sector (TOCA, ADVM, CPRX…) (RTTNews)
26.04.19	7 Top Gainers In Healthcare Sector (TLSA, SWAV, CPRX...) (RTTNews)
26.03.19	6 Top Gainers In Healthcare Sector (CPRX, AXSM, CCXI...) (RTTNews)
18.12.18	Catalyst Pharma Inks Deal With Endo For Vigabatrin Tablets (RTTNews)
29.11.18	FDA Approves Catalyst Pharma's Drug To Treat Rare Autoimmune Disorder (RTTNews)
28.11.18	Catalysts That Could Move Catalyst Pharma (RTTNews)
08.11.18	NantKwest Gets A Shot In The Arm, CPRX Awaits FDA Word, FOMX Meets Phase 3 Goals (RTTNews)
29.10.18	Biotech Stocks Facing FDA Decision In November (RTTNews)
30.05.18	AKER Withdraws 510(K), TTOO Turns Head, CPRX, LOXO To Face FDA In Nov. (RTTNews)
10.05.18	FDA Snubs LPCN Again, NVTA Boosts Revenue Outlook, New Lease Of Life For VTVT (RTTNews)
05.04.18	TENX Heartened After Meeting With FDA, RXII To Report Data In May, GALT On Watch (RTTNews)
15.03.18	Clinical Hold On IGNITE DMD Douses SLDB, PTI Awaits Data In Q2, CPRX On Watch (RTTNews)
29.11.17	APEN Gains Steam, SGRY Starting To Heal, AZRX Catches Eyes, No Stopping CPRX (RTTNews)
28.11.17	BIIB & ALKS Team Up For MS Drug, REGN's Eylea Combo Fails Again, AEZS Rises (RTTNews)
22.11.17	First 2-drug HIV Regimen Gets FDA Nod, Starpharma Shines, ARDX Drops RDX7675 (RTTNews)
19.11.17	In The Spotlight: Catalyst Pharmaceuticals (RTTNews)
01.11.17	AZN Gets Speedy Nod, RBP-6000 Just One Step Away From Approval, STML Soars (RTTNews)
05.09.17	Technical Snapshots for These Generic Drugs Stocks -- Catalyst Pharma, Flexion Therapeutics, Supernus Pharma, and Lannett (PR Newswire)
17.08.17	Analyzing the Financial Health of Biotech Companies (PR Newswire)
17.08.17	Analyzing the Financial Health of Biotech Companies (PR Newswire)
25.07.17	Technical Reports on Generic Drugs Equities -- pSivida, Tetraphase Pharma, Catalyst Pharma, and Galectin Therapeutics (PR Newswire)
12.07.17	Biotech Stocks Ride Momentum in Anticipation of Favorable Governmental Policy Environment (PR Newswire)
12.07.17	Biotech Stocks Ride Momentum in Anticipation of Favorable Governmental Policy Environment (PR Newswire)
07.06.17	Generic Drugs Stocks on Investors' Radar -- Catalyst Pharma, Lannett, Evoke Pharma, and Galectin Therapeutics (PR Newswire)
27.04.17	Gainers & Losers Of Apr.26: AKBA, FLKS, BIOL, BABY, FLXN... (RTTNews)
18.04.17	Research Reports Coverage on Generic Drugs Stocks -- Innocoll, Catalyst Pharma, Galectin Therapeutics, and Tetraphase Pharma (PR Newswire)
28.03.17	Gainers & Losers Of Mar.27: APOP, IPXL, ZIOP, FOMX... (RTTNews)
22.03.17	Biotechs Focus on Improving Cancer Pain Management for Enhanced Patient Care (PR Newswire)
22.03.17	Biotechs Focus on Improving Cancer Pain Management for Enhanced Patient Care (PR Newswire)
16.03.17	Gainers & Losers Of Mar.15: CERU, CPRX, ARNA, AKAO, GNCA... (RTTNews)
15.03.17	What's The Catalyst Driving CPRX? (RTTNews)
13.03.17	Research Reports Coverage on Generic Drugs Stocks -- Galectin Therapeutics, Catalyst Pharma, Innocoll, and Tetraphase Pharma (PR Newswire)
23.01.17	How These Generic Drugs Stocks are Faring? -- Catalyst Pharma, Sophiris Bio, Momenta Pharma, and Agile Therapeutics (PR Newswire)
13.12.16	Healthcare Stocks on Investors' Radar -- Sophiris Bio, Catalyst Pharma, Neurocrine Biosciences, and Capital Senior Living (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Catalyst Pharmaceutical Partners Inc.

Aktien Top/Flop

Meistgelesene Nachrichten